XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statement of Stockholders' Equity - USD ($)
$ in Thousands
Total
Capital stock
Capital in excess of par value
Retained earnings
Accumulated foreign currency adjustment attributable to parent
Accumulated defined benefit plans adjustment attributable to parent
Accumulated other comprehensive (loss) income
Treasury stock
Balance at the beginning of the year at Dec. 31, 2020   $ 2,676 $ 921,752 $ 7,094,656 $ (250,748) $ (253,720)   $ (1,565,270)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   8            
Issuance of common stock under employee stock plans     19,446         7,452
Share-based compensation expense     23,593          
Net income $ 450,912     450,912        
Cash dividends paid       (92,167)        
Other       0        
Translation adjustments         (13,953)      
Change in long-term intercompany notes         (5,566)      
Net investment hedge instruments gain (loss), net of tax of $(13,777) and $1,459 for the quarter ended June 30, 2022 and 2021 and $(19,608) and $(4,479) for the six months ended June 30, 2022 and 2021, respectively         13,846      
Amortization of net actuarial loss and other, net of tax of $(326) and $(527) for the quarter ended June 30, 2022 and 2021 and $(652) and $(1,054) for the six months ended June 30, 2022 and 2021, respectively           3,260    
Purchase of treasury stock               (12,878)
Balance at the end of the year at Jun. 30, 2021 6,343,299 2,684 964,791 7,453,401 (256,421) (250,460) $ (506,881) (1,570,696)
Balance at the beginning of the year at Mar. 31, 2021   2,678 928,412 7,267,856 (260,785) (252,090)   (1,565,323)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   6            
Issuance of common stock under employee stock plans     24,226         (492)
Share-based compensation expense     12,153          
Net income 231,679     231,679        
Cash dividends paid       (46,134)        
Other       0        
Translation adjustments         7,547      
Change in long-term intercompany notes         1,329      
Net investment hedge instruments gain (loss), net of tax of $(13,777) and $1,459 for the quarter ended June 30, 2022 and 2021 and $(19,608) and $(4,479) for the six months ended June 30, 2022 and 2021, respectively         (4,512)      
Amortization of net actuarial loss and other, net of tax of $(326) and $(527) for the quarter ended June 30, 2022 and 2021 and $(652) and $(1,054) for the six months ended June 30, 2022 and 2021, respectively           1,630    
Purchase of treasury stock               (4,881)
Balance at the end of the year at Jun. 30, 2021 6,343,299 2,684 964,791 7,453,401 (256,421) (250,460) (506,881) (1,570,696)
Balance at the beginning of the year at Dec. 31, 2021 6,871,884 2,689 1,012,526 7,900,113 (275,365) (195,079)   (1,573,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   6            
Issuance of common stock under employee stock plans     5,898         3,019
Share-based compensation expense     22,527          
Net income 554,820     554,820        
Cash dividends paid       (101,197)        
Other       (1)        
Translation adjustments         (114,576)      
Change in long-term intercompany notes         (23,119)      
Net investment hedge instruments gain (loss), net of tax of $(13,777) and $1,459 for the quarter ended June 30, 2022 and 2021 and $(19,608) and $(4,479) for the six months ended June 30, 2022 and 2021, respectively         60,209      
Amortization of net actuarial loss and other, net of tax of $(326) and $(527) for the quarter ended June 30, 2022 and 2021 and $(652) and $(1,054) for the six months ended June 30, 2022 and 2021, respectively           2,000    
Purchase of treasury stock               (331,379)
Balance at the end of the year at Jun. 30, 2022 6,950,091 2,695 1,040,951 8,353,735 (352,851) (193,079) (545,930) (1,901,360)
Balance at the beginning of the year at Mar. 31, 2022   2,693 1,018,433 8,121,781 (291,511) (194,079)   (1,725,629)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   2            
Issuance of common stock under employee stock plans     9,562         (1,076)
Share-based compensation expense     12,956          
Net income 282,373     282,373        
Cash dividends paid       (50,419)        
Other       0        
Translation adjustments         (87,391)      
Change in long-term intercompany notes         (16,252)      
Net investment hedge instruments gain (loss), net of tax of $(13,777) and $1,459 for the quarter ended June 30, 2022 and 2021 and $(19,608) and $(4,479) for the six months ended June 30, 2022 and 2021, respectively         42,303      
Amortization of net actuarial loss and other, net of tax of $(326) and $(527) for the quarter ended June 30, 2022 and 2021 and $(652) and $(1,054) for the six months ended June 30, 2022 and 2021, respectively           1,000    
Purchase of treasury stock               (174,655)
Balance at the end of the year at Jun. 30, 2022 $ 6,950,091 $ 2,695 $ 1,040,951 $ 8,353,735 $ (352,851) $ (193,079) $ (545,930) $ (1,901,360)